about
Liver transplantation for hepatic tumors: a systematic reviewSuppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinomaTreatment of Acute Antibody-Mediated Rejection.In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis.Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers.Risk Avoidance and Liver Transplantation: A Single-center Experience in a National Network.Years of life that could be saved from prevention of hepatocellular carcinoma.How does age affect the outcome of kidney transplantation in elderly recipients?Estimation of the Survival Benefit Obtainable From Screening for the Early Detection of Pancreatic Cancer.Impact of preoperative infection on outcome after liver transplantation.Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era.Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses.The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human KidneysPrognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement.MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma.Post-reperfusion syndrome during orthotopic liver transplantation, which definition best predicts postoperative graft failure and recipient mortality?Liver and Vena Cava En Bloc Resection for an Invasive Leiomyosarcoma Causing Budd-Chiari Syndrome, Under Veno-Venous Bypass and Liver Hypothermic Perfusion : Liver Hypothermic Perfusion and Veno-Venous Bypass for Inferior Vena Cava Leiomyosarcoma.Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy.Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts.From six thousand transaminases level to three hundred after liver transplantation: a new era seems to be open.Combined liver-dual kidney transplant: Role in expanded donors.Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications.Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome.Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas.Heterotopic auxiliary segment 2-3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastasesEvolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral unitsPreliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational studyThrombolysis for acute pulmonary embolism after major hepatic surgeryReplyWhy is pancreatic adenocarcinoma not screened for earlier?Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant RadiologyLong term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteriaNormothermic and hypothermic oxygenated perfusion for donation after circulatory death in kidney transplantation: do we pay higher risk of severe infection after transplantation?: a case reportHypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled TrialHepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver DonorsHypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical TrialThe histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study
P50
Q27021650-CACF55F0-81E7-4114-B058-223F6F7EE6EDQ34786512-3CCDA98D-7F90-4C31-AAF2-F8A91066A2D4Q38680132-59E8E4F7-3198-4B38-97E0-490894C39D86Q38769327-F36CD750-1E89-4FA4-B980-78C55E0AB838Q38977660-8BF09B49-EAFB-41BA-9064-79C70AEF9C63Q39590477-E0322FAD-7EC4-4383-8ACD-77F3550E2DBDQ40007128-DA191FF8-D9B2-4A72-A222-C05E971018A2Q40162118-F4D1BB30-2245-448C-A8E6-702ED71A6A79Q40233217-99138FBA-3B32-4C5D-AFD0-F67E1B6E4E50Q40358950-411BFB2B-4628-4D24-9B0C-1FA7D45F570FQ40382979-561DCC29-FB70-4F62-ADA0-2DC4041F9174Q40484597-9380774C-557F-4099-A753-3C18EEF8E04EQ41199454-ECE65EF7-DB36-4542-9FE8-D50570CE105AQ41254262-49F186C2-C285-478A-9386-85C7C3E8020DQ42364937-7BC93572-3AE0-4D10-BE11-DE1B15D7CA54Q47103937-4041C4D6-E633-488E-9803-EF1911538F3BQ47284329-80D1575C-9ED6-41DE-A7E9-86278CCAE2F6Q47362716-6281F4F8-683F-4AEF-A430-B3F5BD63115EQ47407597-7A87D093-230C-492C-AAE3-63D1C2934261Q47657981-F961BF6A-8C3A-41AE-8598-1E0FEEADC99FQ47702883-DE7B90D8-BB7A-409C-9DDD-4B355B0EBE08Q47868973-F06174B3-A2E4-4DA3-B1AA-D24EC0DD0BD6Q48297006-E4467C32-AF51-447E-AD61-402518D777DFQ50659359-8B34A8D8-5A66-4A56-8A0E-FA7DB83DDB01Q52390295-D2D17536-61F8-4F04-81AA-45328B2AD2F7Q53612728-44886385-67DA-41A1-8FB7-6EC4A86B4884Q55058147-5DF6D76E-ED37-4F0A-BDBE-EF92E9D9EBF6Q56339281-D46E7170-79A8-47FB-97D5-F9A30AA03671Q56376374-79469B84-9BF3-46D7-81DA-DEE5C5D14AC3Q56378236-939F04A9-23BD-46BC-845A-6F678A987BACQ56927885-90B92E81-06DE-4CFF-BA11-4EC5E091BE55Q56961622-3E527DC8-41D1-45B3-ACD7-F059E206BAE7Q56963272-035AED37-7B87-4C8B-BCB3-5F6D824DF619Q58554792-066EBFA9-3DC7-4AD6-A0D4-E9FEA2B45FE9Q64054771-06DE3831-7221-4769-8986-DC250E8882F4Q89635135-648D3BED-E732-410E-B5B5-06B6B599041FQ90455081-447C0B7E-46FF-433F-8FBA-93C89AF384B7Q91097680-E2D3E524-9E33-40F7-ADB0-E8A454E505C5Q91739017-49F55869-A9BA-44CA-AA6C-89B9B9ACF394Q92472223-405CCE14-6A42-4784-ACC1-0CCABDAA0291
P50
description
researcher
@en
wetenschapper
@nl
name
Matteo Ravaioli
@en
Matteo Ravaioli
@nl
type
label
Matteo Ravaioli
@en
Matteo Ravaioli
@nl
prefLabel
Matteo Ravaioli
@en
Matteo Ravaioli
@nl
P31
P496
0000-0001-5862-6151